Skip to main content
Caplight Logo









PicturaBio

PicturaBio

Private
OxfordHealthcare & Life Scienceshttps://pictura.bio/

Last Round

Grant

May 24, 2023

Total Funding Raised

$9.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PicturaBio is a medical technology company that develops a rapid pathogen detection platform using single-molecule fluorescent microscopy and machine learning to identify infectious diseases at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Biotechnology, Defense Tech

Business Model

B2G

Customer Profile

Government Contracts, Hardware + Subscription, Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

pathogen detectionpoint-of-care diagnosticsPOC diagnosticsrapid diagnosticsdiagnostic AIinfectious disease diagnosticsfluorescent microscopymedical imaging AImedical devicediagnostic platformbiodefensemilitary diagnosticsuniversal reagenthardware and consumablesveterinary diagnosticsfood safety testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PicturaBio Comparables

Compare PicturaBio with similar companies based on industry and business-model similarity.

PicturaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abbott Laboratories
69%
Pattern Bioscience
67%
Neomend
64%

PicturaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 24, 2023
GrantOct 17, 2022
Pre SeedFeb 15, 2022

Key People

Founding team and executive leadership

Tom Amies

Consultant CFO

Executive Team

PicturaBio Investors

Notable investors and investment history

PicturaBio investors
InvestorRounds
Flu LabPre Seed
IQ CapitalPre Seed
Innovate UKGrant
Defence and Security AcceleratorGrant
Science Creates VenturesPre Seed
Ahren Innovation CapitalPre Seed
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Open roles increased to 4, 2.7x the trailing average.

  • May 24, 2023

    $620K raised from Defence and Security Accelerator.

PicturaBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PicturaBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PicturaBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range15
Year Founded2022
Last FundingMay 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?